Compare Citius Pharmaceuticals Inc (CTXR) vs Manulife Financial Corporation (MFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Manulife Financial Corporation — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Manulife Financial Corporation trades at $43.84 (market cap $72.68B). The key difference: Manulife Financial Corporation is far larger — about 3632.2× Citius Pharmaceuticals Inc's market cap, and Manulife Financial Corporation pays a 3.1% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | MFC | |
|---|---|---|
Market Cap | $20.01M | $72.68B |
Sector | Health | Financials |
52-Week High | $1.82 | $44.77 |
52-Week Low | $0.48 | $30.06 |
Enterprise Value | $16.23M | $67.84B |
Dividend Yield | — | 3.1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Manulife Financial Corporation
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →
